TENX logo

Tenax Therapeutics (TENX) Shareholders Equity

Annual Shareholders Equity

$8.10 M
+$6.61 M+442.51%

December 31, 2023

Summary

Performance

1-Year Change

+442.51%

3-Year Change

+75.07%

5-Year Change

-31.21%

15-Year Change

-8.82%

TENX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.99%
TENX annual stockholders equity is higher than 29.99% of companies in Healthcare sector

High & Low

All-time High

$82.89 M
TENX annual stockholders equity is currently -90.23% below its historical high of $82.89 million

3-Year Low

$1.49 M
TENX annual stockholders equity is currently +442.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TENX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 14, 2025
TENX next annual earnings announcement is scheduled for May 14, 2025

OtherTENXbalance sheetmetrics:

Annual Retained Earnings

-$297.25 M
TENX annual retained earnings is -$297.25 million

Annual Working Capital

$8.10 M
TENX annual working capital is $8.10 million

Annual Total Assets

$11.68 M
TENX annual total assets is $11.68 million

Annual Total Liabilities

$3.59 M
TENX annual total liabilities is $3.59 million

Quarterly Shareholders Equity

$97.22 M
+$88.35 M+995.34%

September 30, 2024

Summary

Performance

3-Month Change

+995.34%

1-Year Change

+682.18%

3-Year Change

+635.33%

5-Year Change

+635.33%

TENX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.91%
TENX quarterly stockholders equity is higher than 57.91% of companies in Healthcare sector

High & Low

All-time High

$97.22 M
TENX quarterly stockholders equity is currently at an all-time high

3-Year Low

$1.49 M
TENX quarterly stockholders equity is currently +6413.24% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TENX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 14, 2025
TENX next earnings announcement is scheduled for May 14, 2025

OtherTENXbalance sheetmetrics:

Quarterly Retained Earnings

-$308.59 M
TENX quarterly retained earnings is -$308.59 million

Quarterly Working Capital

$97.22 M
TENX quarterly working capital is $97.22 million

Quarterly Total Assets

$99.78 M
TENX quarterly total assets is $99.78 million

Quarterly Total Liabilities

$2.56 M
TENX quarterly total liabilities is $2.56 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$8.10 M
TENX annual stockholders equity is $8.10 million

Annual Total Assets

$11.68 M
TENX annual total assets is $11.68 million

Annual Total Liabilities

$3.59 M
TENX annual total liabilities is $3.59 million

TENX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+442.5%+682.2%
3 y3 years+75.1%+635.3%
5 y5 years-31.2%+635.3%

TENX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+442.5%at high+6413.2%
5 y5-yearat high+442.5%at high+6508.9%
alltimeall time-90.2%+317.4%at high+2709.5%

Tenax Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$97.22 M(+995.3%)
Jun 2024
-
$8.88 M(-28.6%)
Mar 2024
-
$12.43 M(+53.5%)
Dec 2023
$8.10 M(+442.5%)
$8.10 M(-28.3%)
Sep 2023
-
$11.29 M(-14.6%)
Jun 2023
-
$13.22 M(-7.4%)
Mar 2023
-
$14.28 M(+856.5%)
Dec 2022
$1.49 M(-64.8%)
$1.49 M(-62.2%)
Sep 2022
-
$3.95 M(-41.7%)
Jun 2022
-
$6.78 M(+322.4%)
Mar 2022
-
$1.61 M(-62.2%)
Dec 2021
$4.24 M(-8.2%)
$4.24 M(-41.4%)
Sep 2021
-
$7.24 M(+392.1%)
Jun 2021
-
$1.47 M(-52.5%)
Mar 2021
-
$3.10 M(-33.1%)
Dec 2020
$4.63 M(+22.6%)
$4.63 M(-37.5%)
Sep 2020
-
$7.40 M(+144.4%)
Jun 2020
-
$3.03 M(-11.4%)
Mar 2020
-
$3.42 M(-9.4%)
Dec 2019
$3.77 M(-68.0%)
$3.77 M(-42.3%)
Sep 2019
-
$6.54 M(-24.2%)
Jun 2019
-
$8.62 M(-16.6%)
Mar 2019
-
$10.34 M(-12.2%)
Dec 2018
$11.77 M(+32.5%)
$11.77 M(+138.4%)
Sep 2018
-
$4.94 M(-20.8%)
Jun 2018
-
$6.23 M(-22.1%)
Mar 2018
-
$8.00 M(-9.9%)
Dec 2017
$8.88 M(-48.2%)
$8.88 M(-12.6%)
Sep 2017
-
$10.16 M(-9.8%)
Jun 2017
-
$11.27 M(-20.2%)
Mar 2017
-
$14.11 M(-17.7%)
Dec 2016
$17.14 M(-71.6%)
$17.14 M(-63.3%)
Sep 2016
-
$46.69 M(-8.3%)
Jun 2016
-
$50.89 M(-8.0%)
Mar 2016
-
$55.33 M(-13.4%)
Dec 2015
$60.42 M(-14.2%)
-
Oct 2015
-
$63.93 M(-5.1%)
Jul 2015
-
$67.37 M(-4.3%)
Apr 2015
$70.43 M(-15.0%)
$70.43 M(-6.5%)
Jan 2015
-
$75.36 M(-2.9%)
Oct 2014
-
$77.59 M(-4.8%)
Jul 2014
-
$81.54 M(-1.6%)
Apr 2014
$82.89 M(-4761.7%)
$82.89 M(+173.5%)
Jan 2014
-
$30.30 M(+962.2%)
Oct 2013
-
$2.85 M(+152.4%)
Jul 2013
-
$1.13 M(-163.6%)
Apr 2013
-$1.78 M(+413.9%)
-$1.78 M(+11.1%)
Jan 2013
-
-$1.60 M(+2659.7%)
Oct 2012
-
-$58.00 K(-90.9%)
Jul 2012
-
-$638.30 K(+84.5%)
Apr 2012
-$346.00 K
-$346.00 K(-60.3%)
Jan 2012
-
-$871.50 K(-76.6%)
Oct 2011
-
-$3.73 M(+130.3%)
DateAnnualQuarterly
Jul 2011
-
-$1.62 M(-56.6%)
Apr 2011
-$3.72 M(-275.1%)
-$3.72 M(+317.0%)
Jan 2011
-
-$893.20 K(-154.9%)
Oct 2010
-
$1.63 M(-55.2%)
Jul 2010
-
$3.64 M(+71.0%)
Apr 2010
$2.13 M(-31.4%)
$2.13 M(-44.5%)
Jan 2010
-
$3.83 M(-41.9%)
Oct 2009
-
$6.59 M(+96.2%)
Jul 2009
-
$3.36 M(+8.3%)
Apr 2009
$3.10 M(-68.2%)
$3.10 M(-53.0%)
Jan 2009
-
$6.60 M(-26.5%)
Oct 2008
-
$8.99 M(-11.8%)
Jul 2008
-
$10.19 M(+4.5%)
Apr 2008
$9.75 M(<-9900.0%)
$9.75 M(-2228.3%)
Jan 2008
-
-$458.20 K(-73.0%)
Oct 2007
-
-$1.70 M(+84.7%)
Jul 2007
-
-$919.10 K(+3878.8%)
Apr 2007
-$23.10 K(-112.4%)
-$23.10 K(-233.5%)
Jan 2007
-
$17.30 K(-106.6%)
Oct 2006
-
-$261.60 K(+40.9%)
Jul 2006
-
-$185.60 K(-199.7%)
Apr 2006
$186.20 K(-80.4%)
$186.20 K(-68.6%)
Jan 2006
-
$593.70 K(-52.0%)
Oct 2005
-
$1.24 M(-37.7%)
Jul 2005
-
$1.99 M(+109.4%)
Apr 2005
$948.40 K(+25.7%)
$948.40 K(-34.5%)
Jan 2005
-
$1.45 M(+296.8%)
Oct 2004
-
$364.90 K(-60.0%)
Jul 2004
-
$913.00 K(+21.0%)
Apr 2004
$754.30 K(-16.2%)
$754.30 K(-34.5%)
Jan 2004
-
$1.15 M(+3.4%)
Oct 2003
-
$1.11 M(+148.1%)
Jul 2003
-
$449.10 K(-50.1%)
Apr 2003
$900.40 K(-70.9%)
$900.40 K(-27.1%)
Jan 2003
-
$1.24 M(-26.0%)
Oct 2002
-
$1.67 M(-38.1%)
Jul 2002
-
$2.70 M(-12.9%)
Apr 2002
$3.10 M(-31.2%)
$3.10 M(-8.8%)
Jan 2002
-
$3.39 M(-12.4%)
Oct 2001
-
$3.88 M(-10.7%)
Jul 2001
-
$4.34 M(-3.5%)
Apr 2001
$4.50 M(-23.2%)
$4.50 M(-8.5%)
Jan 2001
-
$4.92 M(-6.5%)
Oct 2000
-
$5.26 M(-7.0%)
Jul 2000
-
$5.65 M(-3.4%)
Apr 2000
$5.85 M(-5954.2%)
$5.85 M(-3027.1%)
Jan 2000
-
-$200.00 K(+100.0%)
Oct 1999
-
-$100.00 K(-50.0%)
Jul 1999
-
-$200.00 K
Apr 1999
-$100.00 K(-128.4%)
-
Apr 1998
$351.60 K(-224.5%)
-
Apr 1997
-$282.50 K(-52.7%)
-
Apr 1996
-$597.60 K
-

FAQ

  • What is Tenax Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Tenax Therapeutics?
  • What is Tenax Therapeutics annual shareholders equity year-on-year change?
  • What is Tenax Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Tenax Therapeutics?
  • What is Tenax Therapeutics quarterly shareholders equity year-on-year change?

What is Tenax Therapeutics annual stockholders equity?

The current annual shareholders equity of TENX is $8.10 M

What is the all time high annual shareholders equity for Tenax Therapeutics?

Tenax Therapeutics all-time high annual stockholders equity is $82.89 M

What is Tenax Therapeutics annual shareholders equity year-on-year change?

Over the past year, TENX annual stockholders equity has changed by +$6.61 M (+442.51%)

What is Tenax Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of TENX is $97.22 M

What is the all time high quarterly shareholders equity for Tenax Therapeutics?

Tenax Therapeutics all-time high quarterly stockholders equity is $97.22 M

What is Tenax Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, TENX quarterly stockholders equity has changed by +$84.79 M (+682.18%)